Derivatives of isoindigo, indigo and indirubin and use in treating cancer
Abstract
The compound (derivative of iso indigo) called NATURA is useful although a patient's general health is promoted, and when it prevents or treats cancer, it is specifically useful. Related iso indigo of this compound and others, indigo, and the Inn Jill Bin derivative are designed so that the biological activity or bioavailability of a compound may increase. The method of compounding these derivatives is also indicated. Furthermore, the medicine composite including the carrier who is therapeutically permitted as at least one sort and medicine of an effective quantity of these derivatives, and gets is also indicated. The method for using these medicine composites and compounds is indicated, and the animal suffered from solid tumor cancer at this time is therapeutically medicated with an effective quantity. An animal can be medicated with the medicine composite or compound of the present invention until desired medical treatment or a result is attained.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
57 members in 13 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 2158901 | United States of America | A | |
| 40726702 | United States of America | P | |
| 0239866 | United States of America | W |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| US6566341B1 | United States of America | B1 | |
| CA2469649A1 | Canada | A1 | |
| WO03051900A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002357191A1 | Australia | A1 | |
| EP1458734A1 | European Patent Office (EPO) | A1 | |
| US2004225002A1 | United States of America | A1 | |
| JP2005516938A | Japan | A | |
| US2005154046A1 | United States of America | A1 | |
| CA2547963A1 | Canada | A1 | |
| CA2871459A1 | Canada | A1 | |
| WO2005069933A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US6933315B2 | United States of America | B2 | |
| US2005197381A1 | United States of America | A1 | |
| WO2005069933A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1706112A2 | European Patent Office (EPO) | A2 | |
| US2007027203A1 | United States of America | A1 | |
| JP2007522114A | Japan | A | |
| EP1458734A4 | European Patent Office (EPO) | A4 | |
| EP1706112A4 | European Patent Office (EPO) | A4 | |
| US7582670B2 | United States of America | B2 | |
| US2009325895A1 | United States of America | A1 | |
| US2010098702A1 | United States of America | A1 | |
| EP1458734B1 | European Patent Office (EPO) | B1 | |
| AT484514TThis record | Austria | T | |
| ATE484514T1 | Austria | T1 | |
| DE60237993D1 | Germany | D1 | |
| US7855223B2 | United States of America | B2 | |
| CA2469649C | Canada | C | |
| US2011160157A1 | United States of America | A1 | |
| EP2351564A1 | European Patent Office (EPO) | A1 | |
| US2012058121A1 | United States of America | A1 | |
| US2012070518A1 | United States of America | A1 | |
| HK1160393A | Hong Kong, China | A | |
| JP2012176956A | Japan | A | |
| US2013022609A1 | United States of America | A1 | |
| US8394847B2 | United States of America | B2 | |
| US2013178439A1 | United States of America | A1 | |
| US8563525B2 | United States of America | B2 | |
| JP5383977B2 | Japan | B2 | |
| EP1706112B1 | European Patent Office (EPO) | B1 | |
| PT1706112E | Portugal | E | |
| US8748475B2 | United States of America | B2 | |
| HRP20140536T1 | Croatia | T1 | |
| PL1706112T3 | Poland | T3 | |
| RS53372B | Serbia | B | |
| US2014356373A1 | United States of America | A1 | |
| CA2547963C | Canada | C | |
| JP2015071626A | Japan | A | |
| US9023885B2 | United States of America | B2 | |
| US9040574B2 | United States of America | B2 | |
| US2015231115A1 | United States of America | A1 | |
| EP2351564B1 | European Patent Office (EPO) | B1 | |
| US2015335617A1 | United States of America | A1 | |
| EP3020400A1 | European Patent Office (EPO) | A1 | |
| JP5969255B2 | Japan | B2 | |
| HK1220612A | Hong Kong, China | A | |
| US9962400B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2805123
Titles2
- German
- DERIVATE VON ISOINDIGO, INDIGO UND INDIRUBIN UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON KREBS
- English
- DERIVATIVES OF ISOINDIGO, INDIGO AND INDIRUBINE AND THEIR USE IN THE TREATMENT OF CANCER
Classification
- CPC, 3
- C07H19/23
- A61P35/00
- C07D209/34
- IPC, 9
- A61K31 404
- A61K31 7056
- A61K45 06
- A61P35 00
- C07D209 34
- C07H17 02
- C07H19 02
- C07H19 044
- C07H19 23